Call for Abstract
Scientific Program
7th International Conference on Drug Discovery and Toxicology, will be organized around the theme “New Era Technologies in Drug Formulation & Novelties in Toxicology”
Drug Discovery Congress 2020 is comprised of 20 tracks and 100 sessions designed to offer comprehensive sessions that address current issues in Drug Discovery Congress 2020.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Current trends in label free technologies
- Track 1-2High throughput screening by mass spectroscopy
- Track 1-3Next generation sequencing technologies
- Track 1-4Phenotypic drug discovery
- Track 2-1Analytical toxicology
- Track 2-2Clinical and medicinal toxicology
- Track 2-3Environmental toxicology
- Track 2-4Food and nutritional toxicology
- Track 2-5Forensic toxicology
- Track 3-1Dendrimers
- Track 3-2Development of nanoemulsions
- Track 3-3Micelles for drug targeting
- Track 3-4Nano drugs, Nanomaterial & Biopharmaceuticals
- Track 3-5Nano-biotechnology in drug discovery
- Track 3-6Nanomedicine
- Track 3-7Pharmaceutical Nanotechnology
- Track 3-8Polymeric and ceramic nano particles
- Track 4-1Dose response evaluation
- Track 4-2Exposure assessment
- Track 4-3Identify toxic hazards
- Track 4-4Risk characterization
- Track 5-1Bioprinting
- Track 5-2Human organs-on-a-chip
- Track 5-3Role of artificial intelligence in drug discovery
- Track 5-4Targeting RNA with small molecules
- Track 6-1Bone marrow toxicity
- Track 6-2Hepato and renal toxicology
- Track 6-3Immunotoxicology
- Track 6-4Metal toxicology
- Track 6-5Nanoparticle toxicology
- Track 6-6Neurotoxicology
- Track 6-7Reproductive and developmental toxicology
- Track 7-1Ethical issues
- Track 7-2Importance of species selection
- Track 7-3Management of equipment
- Track 7-4Phases in clinical trails
- Track 8-1 Microelectronics and electronic packaging
- Track 8-2Automated Packaging Machine
- Track 8-3Design for a safer dispensing process
- Track 9-1Convergence Chromatography.
- Track 9-2Electrospray Ionization Mass Spectroscopy.
- Track 9-3High-performance and Immuno-affinity chromatography.
- Track 9-4Hydrophobic Interaction chromatography.
- Track 9-5Optical force chromatography.
- Track 9-6Paper Chromatography Hybridization Assay (PACHA)
- Track 10-1Design and formulation of capsules
- Track 10-2Developments in injectable drug delivery
- Track 10-3new oral drug delivery -mouth dissolving formulation
- Track 10-4Targeted delivery of respiratory vaccines
- Track 10-5Topical Cream-Based Dosage Forms
- Track 11-1Lead optimization in drug metabolism
- Track 11-2Protein Binding site identification
- Track 11-3Structure and ligand based drug design
- Track 12-1Development challenges
- Track 12-2Lead identification and validation
- Track 12-3Natural products in drug discovery
- Track 12-4Quantitative structure activity relationship
- Track 12-5Traditional medicines and herbal therapy
- Track 13-1 Absolute oral bioavailability and disposition kineticsÂ
- Track 13-2Pharmacokinetics in relative bioavalibility
- Track 13-3Theoretical Analysis of Drug Dissolution
- Track 13-4Various Approaches to Enhance Drug Solubility
- Track 14-1Good manufacturing practice (GMP)
- Track 14-2Product safety testing
- Track 14-3Quality control in production process
- Track 14-4Pharmaceutical drug validation
- Track 15-1Drug regulation
- Track 15-2Monitoring techniques
- Track 15-3Pharmacovilance
- Track 15-4Regulatory affairs
- Track 16-1Automation in Pharmaceutical Manufacturing
- Track 16-2Beginning of mass production
- Track 16-3Biomaterials and Biomechanics
- Track 17-1Drug delivery system
- Track 17-2Microencapsulation
- Track 17-3Nasal and Pulmonary routes of administration
- Track 17-4Novel drug targets
- Track 18-1 Target identification in drug discovery
- Track 18-2Personalized medication
- Track 18-3Revive orphan drug
- Track 19-1Diagnosis of disease condition
- Track 19-2Mechanism of action of drugs
- Track 19-3Molecular imaging of drug
- Track 19-4Monitoring patient health
- Track 20-1Generation of Chemical Structures
- Track 20-2Molecular Docking
- Track 20-3Multiscale Molecular Structure
- Track 20-4Pharmachophore modelling